We are live on
!
Find out more
RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
44 hedge funds and large institutions have $18.7M invested in Regulus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 4 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 4
10% more call options, than puts
Call options by funds: $376K | Put options by funds: $343K
0% more funds holding
Funds holding: 44 → 44 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
0.68% less ownership
Funds ownership: 3.76% → 3.08% (-0.68%)
56% less capital invested
Capital invested by funds: $42.6M → $18.7M (-$23.8M)
Holders
44
Holders Change
–
Holders Change %
0%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
14
Reduced
4
Closed
12
Calls
$376K
Puts
$343K
Net Calls
+$33K
Net Calls Change
-$535K
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.02M |
| 2 |
Two Sigma Investments
New York
|
-$1.67M |
| 3 |
Two Sigma Advisers
New York
|
-$1.31M |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$597K |
| 5 |
AI
Atom Investors
Austin,
Texas
|
-$526K |
